Navigation Links
Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
Date:4/17/2008

Prescribing for Better Outcomes Offers Unbiased, Comprehensive Analysis of Drug Research; Site Comes in Response to 2004 Pharmaceutical Suit Against Warner-Lambert

CHAPEL HILL, N.C., April 17 /PRNewswire-USNewswire/ --- Physicians and consumers who want fair and balanced information about the most appropriate uses for prescription medications can now find it using a Web-based resource that provides easily accessible, science-based research about drug uses free from pharmaceutical industry influence.

Prescribing for Better Outcomes, a Web-based educational campaign (http://prescribingforbetteroutcomes.org) designed to provide accurate information about the uses of anti-epileptic drugs for the treatment of bipolar disorder, grew out of a global effort to promote evidence-based research and counter the practice of "off-label marketing," in which drug companies promote uses of their medications that may not be supported by science or approved by the U.S. Food and Drug Administration.

"All patients have unique needs. Sometimes, prescribing a drug for an off-label use is the best option," said Dr. John Oldham, M.D., a psychiatrist and Chief of Staff at The Menninger Clinic and the editor of the Journal of Psychiatric Practice. "But when decisions about off-label prescribing are influenced by explicit and deceptive marketing tactics, it lessens our ability as medical professionals to find the best treatment for individual patients."

Prescribing for Better Outcomes (http://prescribingforbetteroutcomes.org) was launched in direct response to a 2004 lawsuit brought by 50 state attorneys general against pharmaceutical manufacturer Pfizer and its subsidiary, Warner-Lambert. The drug company had been charged with using deceptive marketing tactics to promote off-label sales of its anti-epileptic drug, Neurontin, the brand name for gabapentin. The pervasiveness of Warner-Lambert's off-label marketing techniques was found to increase the likelihood that physicians would prescribe gabapentin for the treatment of bipolar disorder, even though evidence-based research demonstrated that this treatment was largely ineffective.

The Prescribing for Better Outcomes campaign is funded by a portion of the settlement from that landmark case. In addition to the tools and information available at PrescribingforBetterOutcomes.org, the program includes resources for clinical practice and a forthcoming continuing medical education module.

"Deceptive, off-label marketing hurts the public and makes it harder for physicians and other practitioners to give their patients appropriate medical care because they're making decisions based on faulty information," said Tim Carey, M.D., M.P.H., Director of The Cecil G. Sheps Center for Health Services Research at the University of North Carolina at Chapel Hill. "Unfortunately, experience indicates that the practice of off-label marketing extends beyond gabapentin. We hope that Prescribing for Better Outcomes will help physicians to become more aware of the sources and quality of information used to guide patient care."

The Web-based resource PrescribingforBetterOutcomes.org was launched by The Sheps Center. The site will help clinicians and consumers better understand what the research actually shows regarding the efficacy of various antiepileptic drugs, including gabapentin, by providing an unbiased comprehensive analysis of the published research on this class of drugs. The site will later be expanded to include information about other prescription drugs.

"It is unrealistic to expect that medical professionals have time to carefully dissect all of the published research on prescription medication," said Cathy Melvin, Principal Investigator and Director of Child Health Services Research at The Sheps Center. "With access to information that the Prescribing for Better Outcomes program provides, medical professionals will be better informed as they make decisions about patient treatment. The site will also help the public better understand the drugs that have been prescribed to them and allow for a mutually beneficial doctor-patient relationship."


'/>"/>
SOURCE Prescribing for Better Outcomes
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. New study may explain Vioxx side-effects
2. Study Points to Cause of Vioxx Heart Risk
3. Vioxx Ban Tied to Rise in Serious GI Trouble
4. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
5. Vioxx Settlement Puts Painkillers Back in the Spotlight
6. Vioxx Settlement Announced
7. Merck Pays More Than $400 Million to Settle Federal, State Medicaid Fraud Investigation Sparked by Qui Tam Whistleblower Case Detailing Marketing Schemes for Vioxx(R), Zocor(R), Several Other Drugs
8. In Post-Vioxx Era, Biologics are Reviving the Arthritis Treatment Market
9. Special Masters Appointed in Program to Resolve U.S. VIOXX(R) Product Liability Lawsuits
10. Key Vioxx Research Was Written by Merck, Documents Allege
11. NHP Reports Third Quarter 2007 Revenue and FFO Growth and Enhanced Disclosure Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2016)... ... 2016 , ... US Sports Camps has collaborated with State Rugby Organization (SRO), ... this summer. Employing world-class rugby figures, including former Team USA players and college coaches, ... key fundamentals, match play, fitness and more. , “US Sports Camps is honored to ...
(Date:5/6/2016)... Grants Pass, OR (PRWEB) , ... May 06, 2016 , ... ... the eyes. In other seasons, when the weather is too cold, dry or hot, ... weather, the eyes can actually absorb moisture from the surrounding air. There’s only one ...
(Date:5/6/2016)... New York, NY (PRWEB) , ... May 06, 2016 , ... ... Pelagos Hotel & Resort on the north end of the island close to the ... from July 17th- August 10th 2016. , “We continue to have an amazing ...
(Date:5/6/2016)... , ... May 06, 2016 , ... ... online provider of career-focused education and corporate training, and the National Military Family ... to announce Maritza Aquino as the second full-tuition scholarship recipient of 2016. ...
(Date:5/5/2016)... ... ... TransWipe Volume 3 is a set of 30 professional transition animations created ... two video clips to instantly add a unique transition to any Final Cut Pro ... orientation options. TransWipe Volume 3 is a Final Cut Pro X exclusive plugin. , ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute lymphocytic Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Leukemia Market and Competitive Landscape Highlights 2016, ... pipeline products, Acute Lymphocytic Leukemia epidemiology, Acute ...
(Date:5/3/2016)... Research and Markets has announced ... Therapy Market Outlook 2020" report to their offering. ... ,Recombinant technology has improved significantly in past years due ... in coming years. Many cancer drugs have been developed ... are also expected to be developed with its help. ...
(Date:5/3/2016)... ACME Markets, Delaware County ... Councilman Dave White announced today the availability ... pharmacies across Delaware County . According ... has saved 26,463 lives nationwide over the past 20 years. Since ... were authorized to administer naloxone to overdose victims, 244 lives ...
Breaking Medicine Technology: